Zobrazeno 1 - 10
of 188
pro vyhledávání: '"M, Varenna"'
Autor:
M. Rossini, F.P. Cantatore, A. Del Puente, B. Frediani, D. Gatti, S. Giannini, M. Varenna, O. Viapiana, G.D. Sebastiani
Publikováno v:
Reumatismo, Vol 76, Iss 2 (2024)
Objective. Fragility fractures (FF) resulting from osteoporosis pose a significant public health challenge in Italy, with considerable socio-health and economic implications. Despite the availability of safe and effective drugs, osteoporosis remains
Externí odkaz:
https://doaj.org/article/4c8e6035cffb4a33824ff6a0c43bb45d
Publikováno v:
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA.
Autor:
M. Manara, M. Varenna
Publikováno v:
Reumatismo, Vol 66, Iss 2, Pp 184-196 (2014)
Bone marrow edema (BME) is a descriptive term which identifies a specific magnetic resonance imaging (MRI) pattern that can be observed in a number of clinical entities, which are often characterized by pain as their main symptom, but show significan
Externí odkaz:
https://doaj.org/article/ca7b68c771ea44489251bb058d0c9984
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
M. Varenna, F. Bertoldo, M. Di Monaco, A. Giusti, G. Martini, M. Rossini, On behalf of SIOMMMS, Endorsed by SIR
Publikováno v:
Reumatismo, Vol 65, Iss 4, Pp 143-166 (2013)
The range of osteoporosis treatments is increasingly large and, like any disease, the pharmacological management of patients should involve a risk/benefit evaluation to attain the greatest reduction in risk of fracture with the lowest incidence of ad
Externí odkaz:
https://doaj.org/article/0af7ef6fcee94d35b45939f9964fe16b
Autor:
M. Rossini, G. D'Avola, M. Muratore, N. Malavolta, F. Silveri, G. Bianchi, B. Frediani, G. Minisola, M. L. Sorgi, M. Varenna, R. Foti, G. Tartarelli, G. Orsolini, S. Adami
Publikováno v:
Reumatismo, Vol 65, Iss 3, Pp 113-120 (2013)
Vitamin D deficiency is very common in patients with rheumatoid arthritis (RA). Aim of this study was to evaluate the prevalence of vitamin D deficiency among the different Italian regions and whether these variations are associated with different se
Externí odkaz:
https://doaj.org/article/e1a65c9cb8d7472a81808a848d1ade69
Publikováno v:
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA. 34(1)
Tumor-induced osteomalacia (TIO) is a rare paraneoplastic syndrome caused by tumoral overproduction of FGF-23. Due to local recurrence, we describe the long-term efficacy and safety profile of burosumab, an anti-FGF-23 monoclonal antibody, in a TIO p
Autor:
M. Rossini, G. Rini, R. Nuti, S. Minisola, S. Migliaccio, C. Mereu, L. Masi, C. Marcocci, E. Mannarino, G. Luisetto, G.C. Isaia, S. Gonnelli, S. Giannini, B. Frediani, E. Fiore, P. Filipponi, C. Cepollaro, M.L. Brandi, F. Bertoldo, S. Adami, M. Varenna, L. Ventura, G. Bianchi
Publikováno v:
Reumatismo, Vol 61, Iss 4, Pp 260-284 (2011)
The guidelines for the osteoporosis management were first drafted by a working group and then critically evaluated by the board of SIOMMMS. The most relevant points are: Definition: Osteoporosis is defined as a quantitative and qualitative deteriorat
Externí odkaz:
https://doaj.org/article/89fc9c5bae5b464c818c72dac5d1d6c3
Autor:
M. Varenna, D. Gatti
Publikováno v:
Reumatismo, Vol 62, Iss 3, Pp 163-171 (2011)
Osteoporosis is a skeletal disease affecting millions of people worldwide in which a decreased bone mass and a microarchitectural deterioration compromise bone strength leading to bone fragility and increased susceptibility to fracture. Bone turnover
Externí odkaz:
https://doaj.org/article/21cb812c3ffa4c49826e1bec1bf791e9
Autor:
L. Sinigaglia, M. Varenna
Publikováno v:
Reumatismo, Vol 61, Iss 1, Pp 4-9 (2011)
Effective drug therapies are available for a wide range of chronic medical conditions but adherence to medications is currently low with poor health outcomes. Evidences support that drug nonadherence is a universal problem more than a disease- and dr
Externí odkaz:
https://doaj.org/article/adfec76cc0d54faa9bee86ab7fd847a5